I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.78 THB -4.55% Market Closed
Market Cap: 2.3B THB
Have any thoughts about
Inter Pharma PCL?
Write Note

Balance Sheet

Balance Sheet Decomposition
Inter Pharma PCL

Current Assets 1.2B
Cash & Short-Term Investments 384.2m
Receivables 427.9m
Other Current Assets 357.6m
Non-Current Assets 1.8B
Long-Term Investments 43.7m
PP&E 946.9m
Intangibles 687.1m
Other Non-Current Assets 114.4m
Current Liabilities 480.8m
Accounts Payable 199.2m
Accrued Liabilities 40.1m
Short-Term Debt 46.1m
Other Current Liabilities 195.4m
Non-Current Liabilities 552.1m
Long-Term Debt 249.8m
Other Non-Current Liabilities 302.3m

Balance Sheet
Inter Pharma PCL

Rotate your device to view
Balance Sheet
Currency: THB
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
9
6
36
32
343
152
174
776
412
Cash
9
6
36
32
343
152
174
776
412
Cash Equivalents
0
0
0
0
0
0
0
0
0
Short-Term Investments
0
0
0
0
0
1
1
1
1
Total Receivables
10
41
38
84
105
156
293
392
425
Accounts Receivables
7
14
35
79
90
124
258
340
337
Other Receivables
3
27
3
5
15
32
35
52
88
Inventory
3
19
14
56
51
108
192
333
352
Other Current Assets
1
1
1
3
6
1
7
13
13
Total Current Assets
24
68
89
176
505
417
667
1 515
1 203
PP&E Net
5
5
7
11
10
255
457
881
929
PP&E Gross
5
5
7
11
10
255
457
881
929
Accumulated Depreciation
2
4
3
3
4
38
54
298
339
Intangible Assets
0
0
0
0
1
49
55
168
197
Goodwill
0
0
0
0
0
22
22
478
478
Note Receivable
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
6
6
5
5
0
10
9
44
Other Long-Term Assets
0
1
3
4
5
13
116
39
101
Other Assets
0
0
0
0
0
22
22
478
478
Total Assets
29
N/A
80
+177%
105
+31%
195
+87%
526
+169%
756
+44%
1 327
+75%
3 090
+133%
2 952
-4%
Liabilities
Accounts Payable
2
13
7
43
17
59
70
194
201
Accrued Liabilities
1
0
0
13
8
12
16
35
47
Short-Term Debt
0
0
0
12
9
11
131
49
46
Current Portion of Long-Term Debt
0
0
0
0
0
16
36
103
93
Other Current Liabilities
3
20
17
20
22
63
83
118
92
Total Current Liabilities
7
33
24
87
56
160
336
498
479
Long-Term Debt
0
0
0
0
0
93
189
387
260
Deferred Income Tax
0
0
0
0
0
0
0
55
59
Minority Interest
0
9
5
6
10
17
22
190
205
Other Liabilities
0
1
2
1
4
16
19
33
36
Total Liabilities
8
N/A
43
+469%
31
-27%
95
+203%
70
-26%
286
+308%
565
+97%
1 164
+106%
1 039
-11%
Equity
Common Stock
5
5
40
65
103
103
149
186
186
Retained Earnings
16
32
33
36
66
80
139
260
247
Additional Paid In Capital
0
0
0
0
287
287
474
1 480
1 480
Total Equity
21
N/A
37
+73%
73
+98%
101
+37%
456
+353%
470
+3%
762
+62%
1 926
+153%
1 913
-1%
Total Liabilities & Equity
29
N/A
80
+177%
105
+31%
195
+87%
526
+169%
756
+44%
1 327
+75%
3 090
+133%
2 952
-4%
Shares Outstanding
Common Shares Outstanding
10
14
113
183
290
290
484
605
605

See Also

Discover More